VanEck Associates’s Bruker BRKR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-7,744
Closed -$284K 1421
2025
Q3
$284K Hold
7,744
﹤0.01% 1253
2025
Q2
$284K Sell
7,744
-84,473
-92% -$3.26M ﹤0.01% 1221
2025
Q1
$3.85M Buy
92,217
+8,213
+10% +$427K 0.01% 812
2024
Q4
$4.92M Buy
84,004
+27,553
+49% +$1.63M 0.01% 700
2024
Q3
$3.37M Buy
56,451
+7,881
+16% +$509K ﹤0.01% 781
2024
Q2
$3.1M Buy
48,570
+3,608
+8% +$272K ﹤0.01% 752
2024
Q1
$4.22M Buy
44,962
+6,647
+17% +$535K 0.01% 653
2023
Q4
$2.81M Buy
38,315
+4,874
+15% +$312K 0.01% 714
2023
Q3
$2.08M Buy
33,441
+7,443
+29% +$501K ﹤0.01% 739
2023
Q2
$1.92M Buy
25,998
+553
+2% +$42.2K ﹤0.01% 738
2023
Q1
$2.01M Buy
25,445
+22,269
+701% +$1.61M ﹤0.01% 712
2022
Q4
$217K Buy
3,176
+349
+12% +$22.2K ﹤0.01% 1075
2022
Q3
$150K Buy
2,827
+254
+10% +$15.2K ﹤0.01% 1091
2022
Q2
$161K Buy
2,573
+12
+0.5% +$736 ﹤0.01% 1116
2022
Q1
$165K Sell
2,561
-13,355
-84% -$913K ﹤0.01% 1140
2021
Q4
$1.34M Buy
15,916
+4,348
+38% +$349K ﹤0.01% 794
2021
Q3
$903K Buy
+11,568
New +$962K ﹤0.01% 829

Other funds holding BRKR

VanEck Associates's BRKR Position: Q4 2025 in Review

VanEck Associates sold out of Bruker (BRKR) in Q4 2025, closing a stake of 7,744 shares — an estimated $284K sold.

VanEck Associates first reported a position in BRKR in Q3 2021 and held it in 17 quarters. The position peaked at $4.92M in Q4 2024. 355 funds tracked by Wall St. Rank hold BRKR as of Q4 2025.

  • VanEck Associates reported no remaining Bruker position as of Q4 2025 after selling out during the quarter.
  • VanEck Associates sold 7,744 Bruker shares in Q4 2025, an estimated $284K.
  • VanEck Associates first reported a position in Bruker in Q3 2021 and held it in 17 quarters.
  • VanEck Associates's Bruker position peaked at $4.92M in Q4 2024.
  • 355 funds tracked by Wall St. Rank held Bruker as of Q4 2025.

Based on VanEck Associates's 13F filing for Q4 2025, filed 13 Feb 2026.